Predicate’s OpenDx Platform is a pioneering clinical management and decision-support tool, designed to enhance the early detection and treatment of serious illnesses, notably sepsis. This innovative platform is the first in the world to synergize two key technological advancements: wearable biosensors and natural language processing (NLP). Analyzed data from both wearable and NLP is pivotal in providing healthcare providers with early, actionable insights, enabling more precise treatment strategies.
Learn more at http://www.predicatehpg.com/
Nine companies will compete on the Main Stage for $10,000 in prizes.